Results for tag: "Endoplasmin"

The Endoplasmin market within the context of Oncology Drugs is a rapidly growing sector of the pharmaceutical industry. Endoplasmin is a type of drug used to treat cancer, and is often used in combination with other treatments such as chemotherapy and radiation. Endoplasmin works by targeting and destroying cancer cells, while leaving healthy cells unharmed. Endoplasmin is also used to reduce the side effects of other treatments, such as nausea and fatigue. Endoplasmin is typically administered intravenously, and is available in both generic and branded forms. The Endoplasmin market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, AstraZeneca, and Bristol-Myers Squibb. Other companies such as Amgen, Eli Lilly, and GlaxoSmithKline also offer Endoplasmin products. Show Less Read more